LEUROSINE (2885)

Compound Details

NameLEUROSINE
Compound class5934812132023436670
Compound codeINDOLE ALKALOID

Summary

Compound class: 5934812132023436670

Experiments: 144

View Experiments

Experiments (144)

Filters
Worktypes (47)
66
51
43
32
29
21
11
8
8
8
6
6
5
5
5
5
5
5
4
4
4
4
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
No match
Pharmacology (17)
31
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
93
No match
Compounds (250)
144
49
24
23
20
16
15
15
12
11
11
8
8
7
7
7
6
6
6
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
Organisms (109)
16
8
5
5
4
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
No match
144 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)
424497
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
21702
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
21578
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
328251
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072135
PHARMACOLOGY OF COMPOUND - IN VIVO
IMMUNOSUPPRESSANT ACTIVITY
Empty organism
20614
STRUCTURE DETERMINATION OFCMR SPECTRUM REPORTED
Empty organism
21235
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1075696
SYNTHESIS OF ANALOGSPATENT DESCRIBED
Catharanthus roseus (APOCYNACEAE)
25519
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1014557
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORMICROBIAL TRANSFORMATION OF
Streptomyces griseus (STREPTOMYCETACEAE)
14474
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
10537
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
858897
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
1073992
TLC DATA REPORTED
Catharanthus roseus (APOCYNACEAE)
321788
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESHPLC DATA REPORTEDWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1081559
CMR SPECTRUM REPORTED
Empty organism
65737
PRESENT IN (REVIEW)
Catharanthus roseus (APOCYNACEAE)
945334
PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
REVERSE TRANSCRIPTASE INHIBITION
Empty organism
811961
ISOLATION AND IDENTIFICATION OF AN ARTIFACT
Catharanthus lanceus (APOCYNACEAE)
25521
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1081762
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072129
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
21852
ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Catharanthus roseus (APOCYNACEAE)
14486
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1073812
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Catharanthus roseus (APOCYNACEAE)
1141786
CMR SPECTRUM REPORTED
Empty organism
21830
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
14478
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1063490
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
965457
PHARMACOLOGY OF COMPOUND - IN VITRO
THROMBOXANE B-2 SYNTHESIS INHIBITION
Empty organism
1073196
PARTIAL SYNTHESIS OF
Catharanthus roseus (APOCYNACEAE)
10544
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
816218
BIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
25518
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1072131
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
982317
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
21829
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
409888
PATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
337541
STRUCTURE DETERMINATION OFORD SPECTRUM REPORTEDABSOLUTE CONFIGURATION DETERMINEDANTICANCER AND/OR CYTOTOXICITY MARKER CODESTEREOCHEMISTRY DETERMINED FOR
Empty organism
1252362
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
1252373
PRESENT IN (REVIEW)
Catharanthus roseus (APOCYNACEAE)
21828
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
10711
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
1075455
SYNTHESIS OF ANALOGSPARTIAL SYNTHESIS OF
Catharanthus roseus (APOCYNACEAE)
405390
COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
618241
HPLC SEPARATION DATA FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus roseus (APOCYNACEAE)
1075649
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
14473
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
990014
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072136
PHARMACOLOGY OF COMPOUND - IN VIVO
PARASYMPATHOLYTIC ACTIVITY
Empty organism
1083253
PRESENT IN (REVIEW)SYNTHESIS OF ANALOGSSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEPREPARATION OF DERIVATIVES OFANTICANCER AND/OR CYTOTOXICITY MARKER CODEREVIEW OF
Catharanthus roseus (APOCYNACEAE)
25520
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
21831
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
341108
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
10538
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus pusillus (APOCYNACEAE)
851696
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
918632
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISISOLATION FROM DURING BIOSYNTHESIS STUDY
Catharanthus roseus (APOCYNACEAE)
615312
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
56019
UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072132
PHARMACOLOGY OF COMPOUND - IN VIVO
LEUKOPENIC ACTIVITY
Empty organism
1142356
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESHPLC DATA REPORTEDIDENTIFICATION IN BY HPLCASSAY FOR
Catharanthus roseus (APOCYNACEAE)
982368
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
22053
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
965458
PHARMACOLOGY OF COMPOUND - IN VITRO
MALONDIALDEHYDE INHIBITION
Empty organism
1063412
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION OF A COMPOUND WITH NOVEL STRUCTUREISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
25516
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
21762
STRUCTURE DETERMINATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus roseus (APOCYNACEAE)
11062
VOUCHER SPECIMEN REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
10561
STRUCTURE DETERMINATION OFPMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
500910
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Catharanthus roseus (APOCYNACEAE)
333061
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
14482
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
14483
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
14477
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1092783
PHARMACOLOGY OF COMPOUND - IN VITRO
FEEDING DETERRENT(INSECT)
Empty organism
1084287
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Catharanthus ovalis (APOCYNACEAE)
1115973
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYIDENTIFICATION OFQUANTITATIVE DATA REPORTED
Catharanthus roseus (APOCYNACEAE)
14488
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
14472
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1092821
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Catharanthus roseus (APOCYNACEAE)
14471
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
982304
PATENT DESCRIBEDCOMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
1207341
MASS-SPECTRAL FRAGMENTATION REPORTEDIDENTIFICATION IN BY GC/MS
Catharanthus roseus (APOCYNACEAE)
1252364
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
411741
COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODESTEREOCHEMISTRY DETERMINED FOR
Catharanthus lanceus (APOCYNACEAE)
982469
PREPARATION OF LABELLLED COMPOUND
Catharanthus roseus (APOCYNACEAE)
25530
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOTENSIVE ACTIVITY
Empty organism
21643
YIELD IS MORE THAN 100 MGMQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1233894
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
411510
CMR SPECTRUM REPORTED
Empty organism
21691
VOUCHER SPECIMEN REPORTED FORQUANTITATIVE DATAANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
21630
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus longifolius (APOCYNACEAE)
1117661
PLANT TISSUE CULTURE MARKER CODEBIOSYNTHESISIDENTIFICATION IN BY HPLC
Catharanthus roseus (APOCYNACEAE)
22417
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072133
PHARMACOLOGY OF COMPOUND - IN VIVO
DIURETIC ACTIVITY
Empty organism
325989
STRUCTURE DETERMINATION OFCMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
25535
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESVOUCHER SPECIMEN REPORTED FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
809856
COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus lanceus (APOCYNACEAE)
1252069
VOUCHER SPECIMEN REPORTED FORWORK DESCRIBED MAINLY CONCERNS METHODOLOGYISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
394341
AGRONOMIC STUDIES REPORTEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072130
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXICITY ASSESSMENT(QUANTITATIVE)
Empty organism
14484
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
14476
SYNTHESIS OF ANALOGSPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
14481
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1252361
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
612434
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Empty organism
1063396
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
24727
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPERGLYCEMIC ACTIVITY
Empty organism
10536
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
453145
BIOSYNTHESISIDENTIFICATION IN BY HPLCQUANTITATIVE DATA REPORTED
Catharanthus roseus (APOCYNACEAE)
335651
ANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072226
COMPLETE SYNTHESIS REPORTEDREVIEW OF
Catharanthus roseus (APOCYNACEAE)
1252363
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
886829
IDENTIFICATION IN BY TLCQUANTITATIVE DATA
Catharanthus roseus (APOCYNACEAE)
1192489
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
CYTOTOXIC ACTIVITY
Empty organism
811960
ISOLATION AND IDENTIFICATION OF AN ARTIFACT
Catharanthus roseus (APOCYNACEAE)
321464
WORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
21642
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1116668
ISOLATION FOLLOWING BIOLOGICAL CONVERSION BY
Catharanthus roseus (APOCYNACEAE)
1095002
IDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Catharanthus roseus (APOCYNACEAE)
14475
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
11115
SEPARATION OFINDICATION BY COLOR REACTIONSTLC DATA REPORTED
Empty organism
615224
COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus lanceus (APOCYNACEAE)
1081490
PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE
ANTIHYPERLIPEMIC ACTIVITY
Empty organism
65735
PRESENT IN (REVIEW)
Catharanthus roseus (APOCYNACEAE)
21670
ISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
1072134
PHARMACOLOGY OF COMPOUND - IN VIVO
TOXIC EFFECT(GENERAL)
Empty organism
14480
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
418615
PHARMACOLOGY OF COMPOUND - IN VITRO
REVERSE TRANSCRIPTASE INHIBITION
Empty organism
21575
YIELD IS MORE THAN 100 MGMISOLATION AND IDENTIFICATION OF
Catharanthus roseus (APOCYNACEAE)
14485
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
21573
PARTIAL STRUCTURE ELUCIDATION OFPMR SPECTRUM REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Catharanthus roseus (APOCYNACEAE)
14479
WORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUESPHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYPATENT DESCRIBEDANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
ANTITUMOR ACTIVITY
Catharanthus roseus (APOCYNACEAE)
1252371
PRESENT IN (REVIEW)
Catharanthus roseus (APOCYNACEAE)
1141951
PMR SPECTRUM REPORTED
Empty organism
980926
COMPLETE SYNTHESIS REPORTED
Catharanthus roseus (APOCYNACEAE)
406024
SYNTHESIS OF ANALOGSANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
11022
SEPARATION OFINDICATION BY COLOR REACTIONSTLC DATA REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
1252360
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
10554
YIELD IS MORE THAN 100 MGMANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OF
Catharanthus lanceus (APOCYNACEAE)
1020504
PATENT DESCRIBEDPREPARATION OF DERIVATIVES OF
Empty organism
24726
PHARMACOLOGY OF COMPOUND - IN VIVO
HYPOGLYCEMIC ACTIVITY
Empty organism
407684
PARTIAL SYNTHESIS OFANTICANCER AND/OR CYTOTOXICITY MARKER CODE
Empty organism
25517
PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE
ANTITUMOR ACTIVITY
Empty organism
Show SPARQL Queries (1)